HORIZON PHARMA INVT LTD's ticker is and the CUSIP is 44052TAB7.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $735,000 | +67.4% | 380,000 | 0.0% | 0.01% | +66.7% |
| Q1 2020 | $439,000 | -12.9% | 380,000 | 0.0% | 0.00% | +50.0% |
| Q4 2019 | $504,000 | +13.5% | 380,000 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $444,000 | +5.2% | 380,000 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $422,000 | -94.4% | 380,000 | -94.9% | 0.00% | -95.2% |
| Q3 2018 | $7,546,000 | +4.9% | 7,500,000 | 0.0% | 0.04% | -4.5% |
| Q2 2018 | $7,192,000 | +3.9% | 7,500,000 | 0.0% | 0.04% | -2.2% |
| Q1 2018 | $6,920,000 | -1.1% | 7,500,000 | 0.0% | 0.04% | +25.0% |
| Q4 2017 | $7,000,000 | +3.2% | 7,500,000 | 0.0% | 0.04% | -30.8% |
| Q3 2017 | $6,785,000 | +4.2% | 7,500,000 | 0.0% | 0.05% | +8.3% |
| Q2 2017 | $6,510,000 | -43.7% | 7,500,000 | -40.0% | 0.05% | -47.3% |
| Q1 2017 | $11,564,000 | -2.8% | 12,500,000 | 0.0% | 0.09% | -4.2% |
| Q4 2016 | $11,900,000 | -2.2% | 12,500,000 | 0.0% | 0.10% | +9.2% |
| Q3 2016 | $12,172,000 | +6.9% | 12,500,000 | 0.0% | 0.09% | +8.8% |
| Q2 2016 | $11,390,000 | +6.4% | 12,500,000 | 0.0% | 0.08% | +12.7% |
| Q1 2016 | $10,700,000 | – | 12,500,000 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 136,032,000 | $150,514,000 | 5.41% |
| SYMPHONY ASSET MANAGEMENT LLC | 16,000,000 | $17,780,000 | 3.72% |
| CSS LLC/IL | 12,427,000 | $13,791,000 | 0.79% |
| SSI INVESTMENT MANAGEMENT LLC | 8,793,000 | $9,740,000 | 0.72% |
| Worth Venture Partners, LLC | 1,103,000 | $1,227,000 | 0.68% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 29,900,000 | $33,208,000 | 0.64% |
| Sonora Investment Management, LLC | 4,840,000 | $5,374,000 | 0.60% |
| Empyrean Capital Partners, LP | 8,000,000 | $8,875,000 | 0.40% |
| DLD Asset Management, LP | 5,500,000 | $6,129,000 | 0.26% |
| ARROWGRASS CAPITAL PARTNERS (US) LP | 12,500 | $10,496,000 | 0.25% |